Attitudes towards the implementation of psychedelic therapy: Qualitative Study with doctors, psychotherapists, and patients
Nervenheilkunde June 11, 2024 DOI: 10.1055/a-2283-0238 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 31 |
| Population | Physicians, psychotherapists, and (ex-)patients in Germany |
| Topics | Psychedelic-assisted therapy |
| Key findings | Most participants were optimistic about introducing psychedelic therapies and desired patient-centered, risk-minimizing regulation. |
Abstract
ZUSAMMENFASSUNG In 11 Fokusgruppeninterviews diskutierten 31 Teilnehmende, gegliedert in die Zielgruppen Ärzte, Psychotherapeuten und (Ex-)Patienten ihre Einstellungen, Wünsche und Bedenken in Bezug auf die mögliche Einführung psychedelischer Therapien in das deutsche Gesundheitssystem. Folgende Themenbereiche wurden besprochen: Risiken und Potenziale psychedelischer Therapien; Erwartungen und Wünsche; Zulassung, Regulation und Zugänglichkeit; therapeutische Begleitung psychedelischer Therapien; Ausbildung zur Durchführung psychedelischer Therapien; Rahmenbedingungen und Durchführung psychedelischer Therapien; Sicherheitsvorkehrungen; vermutete Wirkfaktoren psychedelischer Therapien und Befürchtungen und Bedenken. Die Teilnehmenden äußerten sich größtenteils optimistisch und wünschten sich eine patientennahme und risikominimierende Regulierung psychedelischer Therapien.
Comparable studies
Other qualitative studies on psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression enrolled in an open-label trial of psilocybin | 2017 | Qualitative study | n = 20 |
| LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Patients with anxiety associated with life-threatening diseases | 2014 | Prospective follow-up with qualitative content analysis | n = 10 |
| Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis Adults aged 22 to 69 with clinically elevated anxiety associated with a cancer diagnosis | 2017 | Qualitative study | n = 13 |
| Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts Participants who completed a psilocybin-facilitated smoking cessation pilot study | 2018 | Qualitative follow-up study using semi-structured interviews and thematic analysis | n = 12 |
| The hidden therapist: evidence for a central role of music in psychedelic therapy Patients undergoing psychedelic therapy with psilocybin for treatment-resistant depression | 2018 | Qualitative study | n = 19 |
Citations in the library
Cites 16
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction Current Drug Abuse Reviews January 9, 2015
- The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis Psychiatry Research January 2, 2020
- MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis The Journal of Clinical Pharmacology October 28, 2021
- A Survey of American Psychiatrists' Attitudes Toward Classic Hallucinogens The Journal of Nervous and Mental Disease May 17, 2018
and 11 more in the library